Artivion
AORT
135 hedge funds and large institutions have $795M invested in Artivion in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 50 increasing their positions, 44 reducing their positions, and 19 closing their positions.
86% more call options, than puts
Call options by funds: $701K | Put options by funds: $376K
14% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 44
1.37% more ownership
Funds ownership: 76.85% → 78.22% (+1.4%)
2% more capital invested
Capital invested by funds: $782M → $795M (+$12.4M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 19
2% less funds holding
Funds holding: 138 → 135 (-3)
Top Buyers
Top Sellers
AORT Hedge Fund Activity: Q4 2019 in Review
135 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Artivion (AORT) for Q4 2019, worth a combined $795M — up 1.6% from $782M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of AORT and 18 opened new positions — a net loss of 1 holder — while 44 trimmed existing stakes and 50 added.
The largest buyer was ArrowMark Colorado Holdings, adding an estimated $6.57M. The largest seller was Royce & Associates, cutting an estimated $6.16M.
- 135 institutional investors held Artivion (AORT) as of Q4 2019, down from 138 in Q3 2019.
- Funds reported $795M of Artivion stock for Q4 2019, up 1.6% quarter-over-quarter.
- 18 funds opened new Artivion positions in Q4 2019 and 19 closed out, a net change of -1 holder.
- The largest Artivion buyer in Q4 2019 was ArrowMark Colorado Holdings, an estimated $6.57M added.
- The largest Artivion seller in Q4 2019 was Royce & Associates, an estimated $6.16M sold.
Based on aggregated 13F filings for Q4 2019.